Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

1
Aarkstore - Fibrinogen Deficiency (Factor I
Deficiency) - Pipeline Review, H2 2014
www.aarkstore.com
2
Summary

• Fibrinogen Deficiency (Factor I Deficiency) -
  Pipeline Review, H2 2014, provides
• an overview of the Fibrinogen Deficiency (Factor
  I Deficiency)s therapeutic pipeline.
•  
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Fibrinogen Deficiency (Factor I
  Deficiency), complete with comparative
• analysis at various stages, therapeutics
  assessment by drug target, mechanism of action
• (MoA), route of administration (RoA) and molecule
  type, along with latest updates, and
• featured news and press releases. It also reviews
  key players involved in the therapeutic
• development for Fibrinogen Deficiency (Factor I
  Deficiency) and special features on late-stage
• and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Fibrinogen Deficiency
  (Factor I Deficiency)
• - The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• - The report reviews key players involved in the
  therapeutics development for Fibrinogen
  Deficiency (Factor I Deficiency) and enlists all
  their major and minor projects
• - The report summarizes all the dormant and
  discontinued pipeline projects
• - A review of the Fibrinogen Deficiency (Factor I
  Deficiency) products under development by
  companies and universities/research institutes
  based on information derived from company and
  industry-specific sources
• - Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - A detailed assessment of monotherapy and
  combination therapy pipeline projects
• - Coverage of the Fibrinogen Deficiency (Factor I
  Deficiency) pipeline on the basis of target, MoA,
  route of administration and molecule type

www.aarkstore.com
www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage
• - Develop strategic initiatives by understanding
  the focus areas of leading companies
• - Identify and understand important and diverse
  types of therapeutics under development for
  Fibrinogen Deficiency (Factor I Deficiency)
• - Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline
• - Devise corrective measures for pipeline
  projects by understanding Fibrinogen Deficiency
  (Factor I Deficiency) pipeline depth and focus of
  Indication therapeutics
• - Develop and design in-licensing and
  out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and Scope
• - Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline

www.aarkstore.com
www.aarkstore.com
5
Table of Contents

• IntroductionREPORT COVERAGEFibrinogen
  Deficiency (Factor I Deficiency)
  OverviewTherapeutics DevelopmentPipeline
  Products for Fibrinogen Deficiency (Factor I
  Deficiency) - OverviewPipeline Products for
  Fibrinogen Deficiency (Factor I Deficiency) -
  Comparative AnalysisFibrinogen Deficiency
  (Factor I Deficiency) - Therapeutics under
  Development by CompaniesFibrinogen Deficiency
  (Factor I Deficiency) - Pipeline Products
  GlanceLate Stage ProductsClinical Stage
  ProductsFibrinogen Deficiency (Factor I
  Deficiency) - Products under Development by
  CompaniesFibrinogen Deficiency (Factor I
  Deficiency) - Companies Involved in Therapeutics
  DevelopmentBiotest AGChina Biologic Products,
  Inc.

www.aarkstore.com
www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Fibrinogen Deficiency (Factor I Deficiency), H2
  2014Number of Products under Development for
  Fibrinogen Deficiency (Factor I Deficiency) -
  Comparative Analysis, H2 2014Number of Products
  under Development by Companies, H2
  2014Comparative Analysis by Late Stage
  Development, H2 2014Comparative Analysis by
  Clinical Stage Development, H2 2014Products
  under Development by Companies, H2
  2014Fibrinogen Deficiency (Factor I Deficiency)
  - Pipeline by Biotest AG, H2 2014Fibrinogen
  Deficiency (Factor I Deficiency) - Pipeline by
  China Biologic Products, Inc., H2 2014Fibrinogen
  Deficiency (Factor I Deficiency) - Pipeline by
  LFB S.A., H2 2014

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Fibrinogen Deficiency (Factor I Deficiency), H2
  2014Number of Products under Development by
  Companies, H2 2014Comparative Analysis by
  Clinical Stage Development, H2 2014Assessment by
  Monotherapy Products, H2 2014Number of Products
  by Stage and Top 10 Targets, H2 2014Number of
  Products by Stage and Top 10 Mechanism of
  Actions, H2 2014Number of Products by Top 10
  Routes of Administration, H2 2014Number of
  Products by Stage and Top 10 Routes of
  Administration, H2 2014Number of Products by
  Stage and Top 10 Molecule Types, H2 2014

www.aarkstore.com
8
Related Market Research reports

• Blirt S.A. - Product Pipeline Review 2014
• Auris Medical Holding AG - Product Pipeline
  Review 2014
• Integral Molecular, Inc. - Product Pipeline
  Review 2014
• DaVinci Biosciences, LLC - Product Pipeline
  Review 2014
• Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports

• TiGenix NV - Product Pipeline Review 2014
• Egenix, Inc. - Product Pipeline Review 2014
• SkyePharma PLC - Product Pipeline Review 2014
• MediWound Ltd. - Product Pipeline Review 2014
• BioTech Tools s.a. - Product Pipeline Review -
  2014

www.aarkstore.com
10
Aarkstore - Fibrinogen Deficiency (Factor I
Deficiency) - Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com